Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review.

Serhat Bor İsmail H Kalkan Edoardo Vincenzo Savarino Satish S C Rao Tack JanJay PasrichaDavid J Cangemi Jolien Schol Tennekoon Buddhika Karunaratne Matteo Ghisa Nitin K Ahuja Brian E Lacy

Published in: Neurogastroenterology and motility (2024)

Here, we describe the strengths and weaknesses of six classes of prokinetic drugs, including their pharmacokinetic properties, efficacy, safety and tolerability and potential indications.

Keyphrases

biofilm formation
open label
pseudomonas aeruginosa
staphylococcus aureus
clinical practice
escherichia coli
candida albicans
randomized controlled trial
clinical trial
double blind
placebo controlled